Same Disease Different Approaches| How Japan and the US Are fighting COVID 19

    The US and Japan have adopted very different approaches to responding to the COVID-19 pandemic, including on testing, tracking, social distancing, procurement of medical materials and devices and treatment of the illness.  We will know in the next weeks how successful these varying approaches have been.  Please join us for a webinar on April 28 to listen to two medical doctors from Stanford discuss the different approaches that the US and Japan have taken, with reference to the strategies taken in China, Taiwan and South Korea; the results so far in countering the virus; what we can learn from each other; and prospects for containing the virus and restarting economic activity.  Our speakers are individuals with deep expertise in health care and medical devices, but who can speak plain lay language to demystify the complicated issues that COVID-19 raises. We are pleased to present three prominent speakers for the program who will also answer your questions at the end of the program: Fumiaki Ikeno, a Research Associate, Cardiovascular Medicine, Stanford University where he is responsible for pre clinical studies for medical devices and regenerative medicines for cardiovascular diseases. Dr. Ikeno has deep connections to early stage medtech companies in Silicon Valley and Japan and is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.Bryant Lin, clinical associate professor for medicine in the area of primary care and population health at Stanford. He is also Co-Director of Stanford’s Center for Asia Health Research and Education.Cho-Wei “Jowy” Chen, CEO, Taipei Medical University Biomedical Accelerator. He is also a Global Faculty Fellow, Stanford Byers Center for Biodesign.Jack W Moorman (Moderator), Chairman, US-Japan Medtech Frontiers.  Also, Visiting Faculty Member, Graduate School of Medicine, Osaka University, Japan and Partner, Nichibei Advisors, LLCPlease join us for this timely, relevant and practical program.  The program is free.

    149NM
    The US and Japan have adopted very different approaches to responding to the COVID-19 pandemic, including on testing, tracking, social distancing, procurement of medical materials and devices and treatment of the illness.  We will know in the next weeks how successful these varying approaches have been.  Please join us for a webinar on April 28 to listen to two medical doctors from Stanford discuss the different approaches that the US and Japan have taken, with reference to the strategies taken in China, Taiwan and South Korea; the results so far in countering the virus; what we can learn from each other; and prospects for containing the virus and restarting economic activity.  Our speakers are individuals with deep expertise in health care and medical devices, but who can speak plain lay language to demystify the complicated issues that COVID-19 raises.

     
    We are pleased to present three prominent speakers for the program who will also answer your questions at the end of the program:
     
    • Fumiaki Ikeno, a Research Associate, Cardiovascular Medicine, Stanford University where he is responsible for pre clinical studies for medical devices and regenerative medicines for cardiovascular diseases. Dr. Ikeno has deep connections to early stage medtech companies in Silicon Valley and Japan and is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.
    • Bryant Lin, clinical associate professor for medicine in the area of primary care and population health at Stanford. He is also Co-Director of Stanford’s Center for Asia Health Research and Education.
    • Cho-Wei “Jowy” Chen, CEO, Taipei Medical University Biomedical Accelerator. He is also a Global Faculty Fellow, Stanford Byers Center for Biodesign.
    • Jack W Moorman (Moderator), Chairman, US-Japan Medtech Frontiers.  Also, Visiting Faculty Member, Graduate School of Medicine, Osaka University, Japan and Partner, Nichibei Advisors, LLC
    Please join us for this timely, relevant and practical program.  The program is free.